LASP1 and non-small cell lung carcinoma: MiR-29a was claimed to have the ability to decreased proliferation in non-small-cell lung cancer (NSCLC), via negatively correlating with LIM and SH3 domain protein 1 (LASP1), a cAMP- and cGMP-dependent signaling protein and a member of the nebulin family of actin-binding proteins [50].